tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Compare Fulcrum Therapeutics (FULC) vs. Competitors

Compare
516 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Fulcrum Therapeutics
$10.14
$668.94M
-8.60
154.77%
9 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$70.00
$467.78M
-20.36
129.66%
11 Buy
0 Hold
0 Sell
Strong Buy
ADC Therapeutics
$3.62
$448.44M
-2.50
106.86%
3 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$23.71
$1.81B
77.64
311.63%
8 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.05B
-7.06
433.75%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FULC
Fulcrum Therapeutics
10.14
6.14
153.50%
MNPR
Monopar Therapeutics Inc
70.00
38.32
120.96%
ADCT
ADC Therapeutics
3.62
1.86
105.68%
OPT
GLUE
Monte Rosa Therapeutics
23.71
18.02
316.70%
INBX
Inhibrx Biosciences Inc
72.27
58.08
409.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts